DUKE UNIVERSITY

MRI SERVICES

RESEARCH AND DEVELOPMENT PRODUCT STORAGE AND SHIPPING

TECHNICAL EXPERT SERVICES: TECHNICAL EXPERTISE IN PREDICTIVE TOXICOLOGY FOR DRUG-INDUCED LIVER INJURY (DILI)

THE OVERALL OBJECTIVE OF THIS SOW IS TO CREATE A PARTNERSHIP BETWEEN THE AGREEMENT RECIPIENT, DUKE UNIVERSITY ON BEHALF OF DUKE CLINICAL RESEARCH INSTITUTE (DCRI), AND BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA) TO ENHANCE INNOVATI

"EVALUATION AND TESTING SERVICES (ETS) FOR VACCINES AND OTHER BIOLOGICS FOR INFECTIOUS DISEASES - TASK AREAS A & C."

COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 30, 2026)

2023 CLINICAL IMMUNIZATION SAFETY ASSESSMENT (CISA) BASE IDIQ

1500006I DUKE UNIVERSITY

INNOVATIONS IN FUNCTIONAL B CELL EPITOPE DISCOVERY

1300017I DUKE UNIVERSITY; VTEU; TO A4D14.0033--17 CONSULTATION AND TESTING OF CYTOKINE LEVELS AND CELL ACTIVATION IN CLINICAL SAMPLES

ADJUVANT COMPARISON AND CHARACTERIZATION

AN OBSERVATIONAL STUDY OF COCCIDIOIDOMYCOSIS INCIDENCE IN PERSONS PRESENTED WITH COMMUNITY ACQUIRED PNEUMONIA AND OUTCOMES OF ANTIFUNGAL TREATMENT OF COCCIDIOIDOMYCOSIS PNEUMONIA (VALLEY FEVER PNEUMONIA) UNDER STANDARD OF CARE IN ENDEMIC AREAS.

19C00053; COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) COMPONENT B: VACCINE MANUFACTURING AND TOXICOLOGY CORE.

RNA EXTRACTION AND SEQUENCING

TO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2020 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2025, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS.

BRPC LAB SERVICES

NICHD: R&D: BEST PHARMACEUTICALS FOR CHILDREN ACT (BPCA) PEDIATRIC TRIALS NETWORK (PTN): CORE FUNCTION ACTIVITIES - THE CONTRACTOR SHALL ESTABLISH AND MAINTAIN CENTRALIZED TEAMS OF EXPERTS WHO WILL DEVELOP PROTOCOLS AND INFORMED CONSENT FORMS AND

THE FOOD AND DRUG ADMINISTRATION (FDA) IS RESPONSIBLE FOR PROTECTING THE PUBLIC HEALTH BY ASSURING THE SAFETY, EFFICACY, AND SECURITY OF HUMAN AND VETERINARY DRUGS, BIOLOGICAL PRODUCTS, MEDICAL DEVICES, OUR NATION?S FOOD SUPPLY, COSMETICS, AND PRODUC

NICHD: R&D: PHARMACOKINETICS AND SAFETY OF ANESTHETICS AND ANALGESICS IN CHILDREN: NON-SEVERABLE

EOI:: IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI NICHD: R&D: DEFINING THE SAFETY AND EFFICACY OF POSTERIOR TIBIAL NERVE STIMULATION IN CHILDREN (POSITRON-C): NON-SEVERABLE

19C00053; COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) COMPONENT B: VACCINE MANUFACTURING AND TOXICOLOGY CORE.

BRAIN TISSUE PROCESSING WITH DUKE UNIVERSITY

TUITION AND FEES

NICHD: R&D: BPCA PHARMACOLOGY STUDIES (TO2): NON-SEVERABLE

LABORATORY SERVICE WITH DUKE UNIVERSITY AT DURHAM VAMC

RAW DATA COLLECTION: PROTEIN ID BY ORBITRAP ASTRAL WITH EVOSEP ONE UPLC WITH 40MIN GRADIENT DUKE UNIV MED CTR:1109092 [25-007545]

NEUROIMAGING AND DATA ANALYTICS SERVICES

EOI::{RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING}::EOI{BILATERAL MODIFICATION TO DESCOPE}

EXTERNAL QUALITY ASSURANCE PROGRAM OVERSIGHT LABORATORY (EQAPOL)

IMMUNOLOGY QUALITY ASSESSMENT (IQA) PROGRAM

EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 30, 2026)

EOI::{RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING}::EOI{BILATERAL MODIFICATION TO DESCOPE}

NATIONAL DATA ARCHIVE ON CHILD ABUSE AND NEGLECT (NDACAN) OPERATION AND MAINTENANCE SERVICES

TUITION AND FEES

NICHD: R&D: BPCA PEDIATRIC DRUG DEVELOPMENT CLINICAL TRIAL INFRASTRUCTURE: SEVERABLE

EOI::IMPLEMENTING THE PRESIDENT'S DOGE COST EFFICIENCY INITIATIVE::EOI TERMINATION FOR CONVENIENCE AGREEMENT

PERFORM ON LIGHTNING ADVISORY PANEL

DNA ISOLATION & SEQUENCING SERVICES IN COLLABORATION WITH DUKE UNIVERSITY AND DURHAM VAMC.

EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 30, 2026)

HSB117 C 6365 DUKE - NATIONAL CORD BLOOD INVENTORY

EXTERNAL QUALITY ASSURANCE PROGRAM OVERSIGHT LABORATORY (EQAPOL)

19C00053; COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) COMPONENT B: VACCINE MANUFACTURING AND TOXICOLOGY CORE.

THIS CONTRACT WILL SUPPORT COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES, BASED ON PRINCIPLES OF INFLUENZA IMMUNITY, THAT ACHIEVE DURABLE, ROBUST

MRI SERVICES

MRI SERVICES

NICHD: R&D: BEST PHARMACEUTICALS FOR CHILDREN ACT (BPCA) PEDIATRIC TRIALS NETWORK (PTN): CORE FUNCTION ACTIVITIES - THE CONTRACTOR SHALL ESTABLISH AND MAINTAIN CENTRALIZED TEAMS OF EXPERTS WHO WILL DEVELOP PROTOCOLS AND INFORMED CONSENT FORMS AND

P0003 - CLOSEOUT DNA LIBRARY PREPARATION AND SEQUENCING ANALYSIS

THIS CONTRACT WILL PROVIDE LABORATORIES PERFORMING VIROLOGIC TESTING FOR NIAID-SPONSORED CLINICAL TRIALS (LABS) WITH A COMPREHENSIVE QUALITY ASSESSMENT PROGRAM FOR VIROLOGIC ASSAYS FOR HIV AND OTHER VIRAL PATHOGENS INCLUDING PROFICIENCY TESTING PROGR

NATIONAL DATA ARCHIVE ON CHILD ABUSE AND NEGLECT (NDACAN) OPERATION AND MAINTENANCE SERVICES

TASK ORDER #1 AGAINST IDIQ 140G0324D0009 FOR LI, SR, AND B ISOTOPE ANALYSES COMPLETE TERMINATION FOR CONVENIENCE